Novartis Investigative Site

Sydney 2050

0 studies enrolling now · 2 studies all time

What they study most

Chronic Myelogenous Leukemia, Ovarian Cancer

Studies at this site

• Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected — Stopped early
• Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia — Completed